AbbVie Declines After Humira Patent Loss

·

·

AbbVie Declines After Humira Patent Loss

AbbVie (NYSE:ABBV) has lost a patent case against Coherus (NASDAQ:CHRS) in a ruling that was announced on Wednesday. The patent (which covered the treatment of RA with Humira) loss means that biosimilars to Humira could come to the market
See Original Article

Academic Honors

The Wall College offers six majors (accounting, economics, finance, hospitality, resort and tourism management, management and marketing), seven
See Original Article

Billion-Dollar Gold Dream Lures Mining Maverick Out of Hiatus

The Canadian mining magnate's latest target is a subterranean patch of red earth in southwestern Mexico. In January his new undertaking, Leagold
See Original Article

Amazon could 'break open' the pharmacy space, says health tech investor

Health investor Steve Kraus is not surprised that Amazon is considering a push into the pharmacy market. He sees huge opportunities for Amazon to compete with the biggest pharmacies.
See Original Article

Answers Questions & Are There 4U!

The true accounting know-how to reduce your expenses and increase your profits – with the personality of your best friend – keeping things close,
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.